Form 4: Becton Dickinson Director Catherine M. Burzik Reports Stock Transactions

Director Catherine M. Burzik of Becton Dickinson & Co. reported acquiring 930 shares of common stock and disposing of 14,264 shares through dividend reinvestment.

Summary

• Catherine M. Burzik, a director at Becton Dickinson & Co., reported a transaction involving the company's common stock.
• On January 28, 2025, Ms. Burzik acquired 930 shares of common stock.
• These shares were awarded as restricted stock units under the company's 2004 Employee and Director Equity-Based Compensation Plan.
• Additionally, Ms. Burzik disposed of 14,264 shares through dividend reinvestment.
• The reported transactions changed Ms. Burzik's beneficial ownership of Becton Dickinson stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a director, which is neither positive nor negative for the company's performance.

Industry Context

This is a routine filing related to insider trading and is common for directors of publicly traded companies. It provides transparency into the stock transactions of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the United States, ensuring transparency of insider transactions.
• Similar filings are made by directors and officers of companies like Medtronic (MDT) and Abbott Laboratories (ABT), which are also in the medical device industry.
• The volume of shares traded is not unusual for a director's equity compensation and dividend reinvestment.

Stakeholder Impact

• The stock transactions by a director are disclosed to maintain transparency for shareholders.
• The transactions have a minimal impact on the company's operations or other stakeholders.

Key Dates

Keywords

Becton Dickinson, Director, Stock Transaction, Form 4, Beneficial Ownership, Restricted Stock Units, Dividend Reinvestment